Published in J Cardiovasc Electrophysiol on March 01, 2003
Inherited arrhythmic disorders: long QT and Brugada syndromes. Tex Heart Inst J (2007) 0.88
Seasonal, weekly, and circadian distribution of ventricular fibrillation in patients with J-wave syndrome from the J-PREVENT registry. J Arrhythm (2015) 0.78
Spontaneous alternans in Brugada ECG morphology. J Interv Card Electrophysiol (2006) 0.77
Diabetic Dead-in-Bed Syndrome: A Possible Link to a Cardiac Ion Channelopathy. Case Rep Med (2014) 0.75
Comparison of circadian, weekly, and seasonal variations of electrical storms and single events of ventricular fibrillation in patients with Brugada syndrome. Int J Cardiol Heart Vasc (2016) 0.75
ST-T wave changes in a patient complicated with vasospastic angina and Brugada syndrome: differential responses to acetylcholine in right and left coronary artery. Heart Vessels (2008) 0.75
Brugada-like electrocardiographic pattern induced by an episode of anemia. Z Kardiol (2005) 0.75
Appearance of J wave in the inferolateral leads and ventricular fibrillation provoked by mild hypothermia in a patient with Brugada syndrome. HeartRhythm Case Rep (2016) 0.75
A global in vivo Drosophila RNAi screen identifies NOT3 as a conserved regulator of heart function. Cell (2010) 2.27
Impact of plaque morphology on creatine kinase-MB elevation in patients with elective stent implantation. Int J Cardiol (2010) 2.05
Inhibition of IkappaB phosphorylation in cardiomyocytes attenuates myocardial ischemia/reperfusion injury. Cardiovasc Res (2004) 1.99
Late-phase thromboembolism after catheter ablation for paroxysmal atrial fibrillation. Circ J (2014) 1.98
Impact of statin use before the onset of acute myocardial infarction on coronary plaque morphology of the culprit lesion. Angiology (2012) 1.97
Mst1 inhibits autophagy by promoting the interaction between Beclin1 and Bcl-2. Nat Med (2013) 1.93
Drugs and Brugada syndrome patients: review of the literature, recommendations, and an up-to-date website (www.brugadadrugs.org). Heart Rhythm (2009) 1.92
Clinical implications of reconnection between the left atrium and isolated pulmonary veins provoked by adenosine triphosphate after extensive encircling pulmonary vein isolation. J Cardiovasc Electrophysiol (2007) 1.88
Functional characterization of a trafficking-defective HCN4 mutation, D553N, associated with cardiac arrhythmia. J Biol Chem (2004) 1.75
Clinical implications of an implantable cardioverter-defibrillator in patients with vasospastic angina and lethal ventricular arrhythmia. J Am Coll Cardiol (2012) 1.73
Effect of sodium-channel blockade on early repolarization in inferior/lateral leads in patients with idiopathic ventricular fibrillation and Brugada syndrome. Heart Rhythm (2011) 1.71
Impact of adenosine-provoked acute dormant pulmonary vein conduction on recurrence of atrial fibrillation. J Cardiovasc Electrophysiol (2011) 1.70
Ultrasound-microbubble-mediated intercellular adhesion molecule-1 small interfering ribonucleic acid transfection attenuates neointimal formation after arterial injury in mice. J Am Coll Cardiol (2010) 1.68
Prevalence and distribution of sarcomeric gene mutations in Japanese patients with familial hypertrophic cardiomyopathy. Circ J (2011) 1.64
Adiponectin protects against doxorubicin-induced cardiomyopathy by anti-apoptotic effects through AMPK up-regulation. Cardiovasc Res (2010) 1.63
Local unipolar and bipolar electrogram criteria for evaluating the transmurality of atrial ablation lesions at different catheter orientations relative to the endocardial surface. Heart Rhythm (2010) 1.61
Nitric oxide inhibits ischemia/reperfusion-induced myocardial apoptosis by modulating cyclin A-associated kinase activity. Cardiovasc Res (2003) 1.60
Cardiomyocyte proliferation and protection against post-myocardial infarction heart failure by cyclin D1 and Skp2 ubiquitin ligase. Cardiovasc Res (2008) 1.57
Reentrant tachycardia in pulmonary veins of patients with paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol (2003) 1.57
Long-term clinical outcome of extensive pulmonary vein isolation-based catheter ablation therapy in patients with paroxysmal and persistent atrial fibrillation. Heart (2010) 1.55
Renal function after catheter ablation of atrial fibrillation. Circulation (2011) 1.53
Novel SCN3B mutation associated with brugada syndrome affects intracellular trafficking and function of Nav1.5. Circ J (2012) 1.52
Gender and age differences in candidates for radiofrequency catheter ablation of idiopathic ventricular arrhythmias. Circ J (2011) 1.51
New human leukocyte antigen risk allele in Japanese patients with Takayasu arteritis. Circ J (2012) 1.51
The prognostic value of early repolarization (J wave) and ST-segment morphology after J wave in Brugada syndrome: multicenter study in Japan. Heart Rhythm (2012) 1.49
Incidence of late thromboembolic events after catheter ablation of atrial fibrillation. Circ J (2011) 1.48
Left ventricular rupture associated with Takotsubo cardiomyopathy. Mayo Clin Proc (2004) 1.48
Progesterone regulates cardiac repolarization through a nongenomic pathway: an in vitro patch-clamp and computational modeling study. Circulation (2007) 1.48
Effect of low-level clenching and subsequent muscle pain on exteroceptive suppression and resting muscle activity in human jaw muscles. Clin Neurophysiol (2007) 1.46
Toll-like receptor-2 plays a fundamental role in periodontal bacteria-accelerated abdominal aortic aneurysms. Circ J (2013) 1.46
Clinical study regarding the anatomical structures of the right atrial isthmus using intra-cardiac echocardiography: implication for catheter ablation of common atrial flutter. J Interv Card Electrophysiol (2005) 1.45
Ambulatory ECG-based T-wave alternans and heart rate turbulence predict high risk of arrhythmic events in patients with old myocardial infarction. Circ J (2009) 1.45
J wave and fragmented QRS formation during the hyperacute phase in Takotsubo cardiomyopathy. Circ J (2014) 1.44
Assessment of echo-attenuated plaque by optical coherence tomography and its impact on post-procedural creatine kinase-myocardial band elevation in elective stent implantation. JACC Cardiovasc Interv (2011) 1.44
Pitavastatin suppresses acute and chronic rejection in murine cardiac allografts. Transplantation (2007) 1.44
Early treatment with clarithromycin attenuates rat autoimmune myocarditis via inhibition of matrix metalloproteinase activity. Heart (2010) 1.43
Additive effects of β-blockers on renin-angiotensin system inhibitors for patients after acute myocardial infarction treated with primary coronary revascularization. Circ J (2011) 1.43
Catheter ablation of atrial fibrillation in patients with valvular heart disease: long-term follow-up results. J Cardiovasc Electrophysiol (2010) 1.42
Perindopril augments ecto-ATP diphosphohydrolase activity and enhances endothelial anti-platelet function in human umbilical vein endothelial cells. J Hypertens (2003) 1.42
Utility of distinctive local electrogram pattern and aortographic anatomical position in catheter manipulation at coronary cusps. J Cardiovasc Electrophysiol (2010) 1.41
Variability of microcirculatory resistance index and its relationship with fractional flow reserve in patients with intermediate coronary artery lesions. Circ J (2013) 1.41
Synergistic effect of combined HMG-CoA reductase inhibitor and angiotensin-II receptor blocker therapy in patients with chronic heart failure: the HF-COSTAR trial. Circ J (2011) 1.40
Clinical utility of adenosine-infusion test at a repeat atrial fibrillation ablation procedure. Heart Rhythm (2012) 1.40
Coronary artery fistula with a giant aneurysm treated by percutaneous transradial embolization. Catheter Cardiovasc Interv (2012) 1.40
Unmasking Brugada-type electrocardiogram on deep inspiration. Circ J (2013) 1.40
Fragmented QRS predicts cardiovascular death of patients with structural heart disease and inducible ventricular tachyarrhythmia. Circ J (2013) 1.40
Current state of symptomatic aortic valve stenosis in the Japanese elderly. Circ J (2011) 1.39
Clinical effect of implantable cardioverter defibrillator replacements: when should you resume driving after an implantable cardioverter defibrillator replacement? Circ J (2010) 1.39
Clinical assessment of antiarrhythmic agents for paroxysmal atrial fibrillation guided by modification of electrophysiologic arrhythmogenicity. J Cardiovasc Electrophysiol (2004) 1.39
Identical atrio-His interval and A-A intervals during long RP tachycardia: what is the mechanism? Diagnosis: Atypical AVNRT. Circ Arrhythm Electrophysiol (2014) 1.39
Electrocardiography characteristics of isolated non-compaction of ventricular myocardium in Japanese adult patients. Circ J (2010) 1.39
Association of atrial arrhythmia and sinus node dysfunction in patients with catecholaminergic polymorphic ventricular tachycardia. Circ J (2007) 1.38
Resolution of abnormal body surface maps in children with atrial septal defect after intracardiac repair. J Cardiovasc Electrophysiol (2004) 1.38
Amiodarone-induced thyrotoxicosis late after amiodarone withdrawal. Circ J (2013) 1.38
Influence of microvascular resistance on fractional flow reserve after successful percutaneous coronary intervention. Catheter Cardiovasc Interv (2014) 1.38
A sulforaphane analogue that potently activates the Nrf2-dependent detoxification pathway. J Biol Chem (2001) 1.34
ATF3 inhibits doxorubicin-induced apoptosis in cardiac myocytes: a novel cardioprotective role of ATF3. J Mol Cell Cardiol (2002) 1.24
Role of FDG PET-CT in Takayasu arteritis: sensitive detection of recurrences. JACC Cardiovasc Imaging (2012) 1.23
Transcriptional regulation of Fcgr2b gene by polymorphic promoter region and its contribution to humoral immune responses. J Immunol (2002) 1.21
Electrical connections between pulmonary veins: implication for ostial ablation of pulmonary veins in patients with paroxysmal atrial fibrillation. Circulation (2002) 1.20
Macroreentrant atrial tachycardia in patients without previous atrial surgery or catheter ablation: clinical and electrophysiological characteristics of scar-related left atrial anterior wall reentry. J Cardiovasc Electrophysiol (2012) 1.19
Nitric oxide inhibits myocardial apoptosis by preventing caspase-3 activity via S-nitrosylation. J Mol Cell Cardiol (2004) 1.18
Electrocardiographic characteristics of repetitive monomorphic right ventricular tachycardia originating near the His-bundle. J Cardiovasc Electrophysiol (2005) 1.16
Improved prognosis of Takayasu arteritis over the past decade--comprehensive analysis of 106 patients. Circ J (2012) 1.15
Hepatocyte growth factor ameliorates the progression of experimental autoimmune myocarditis: a potential role for induction of T helper 2 cytokines. Circ Res (2005) 1.12
Complex anatomy surrounding the left atrial posterior wall: analysis with 3D computed tomography. Heart Vessels (2011) 1.12
Integrating genetic, transcriptional, and functional analyses to identify 5 novel genes for atrial fibrillation. Circulation (2014) 1.11
Blockade of the interaction between PD-1 and PD-L1 accelerates graft arterial disease in cardiac allografts. Arterioscler Thromb Vasc Biol (2004) 1.11
Curative therapy for swallowing-induced tachycardia by pulmonary vein antrum isolation. J Cardiovasc Electrophysiol (2005) 1.10
In vivo critical fibrous cap thickness for rupture-prone coronary plaques assessed by optical coherence tomography. Eur Heart J (2011) 1.09
Quantitative measures of coronary stenosis severity by 64-Slice CT angiography and relation to physiologic significance of perfusion in nonobese patients: comparison with stress myocardial perfusion imaging. J Nucl Med (2008) 1.09
Serum tenascin-C might be a novel predictor of left ventricular remodeling and prognosis after acute myocardial infarction. J Am Coll Cardiol (2006) 1.07
Long-term follow-up after catheter ablation of paroxysmal atrial fibrillation: the incidence of recurrence and progression of atrial fibrillation. Circ Arrhythm Electrophysiol (2014) 1.06
Induction of premature senescence in cardiomyocytes by doxorubicin as a novel mechanism of myocardial damage. Aging Cell (2007) 1.06
A mutant cardiac sodium channel with multiple biophysical defects associated with overlapping clinical features of Brugada syndrome and cardiac conduction disease. Cardiovasc Res (2002) 1.06
Clinical effectiveness of pulmonary vein isolation for arrhythmic events in a patient with catecholaminergic polymorphic ventricular tachycardia. Heart Vessels (2010) 1.05
Diagnosis and assessment of Takayasu arteritis by multiple biomarkers. Circ J (2012) 1.04
Electrocardiographic and electrophysiologic characteristics of ventricular tachycardia originating within the pulmonary artery. J Am Coll Cardiol (2005) 1.04